Showing results (191-200 of 240) with videos related to
Sort By:
Pageof 24
Cell Cycle (Georgetown, Tex.)|April 11, 2018
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitorsMichael Daskalakis, David Brocks, Yi-Hua Sheng, et al.Journal of Molecular Biology|March 25, 2014
Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen schistosoma mansoniDiana A Stolfa, Martin Marek, Julien Lancelot, et al.Plos Biology|February 19, 2005
SIRT1 regulates HIV transcription via Tat deacetylationSara Pagans, Angelika Pedal, Brian J North, et al.Chemmedchem|May 29, 2018
Synthesis, Crystallization Studies, and in vitro Characterization of Cinnamic Acid Derivatives as SmHDAC8 Inhibitors for the Treatment of SchistosomiasisTheresa Bayer, Alokta Chakrabarti, Julien Lancelot, et al.Journal of Medicinal Chemistry|June 6, 2017
Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell LinesKatharina Stenzel, Alexandra Hamacher, Finn K Hansen, et al.Medchemcomm|December 17, 2013
The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 InhibitorsPaolo Di Fruscia, Ka-Kei Ho, Sasiwan Laohasinnarong, et al.Plos Neglected Tropical Diseases|March 3, 2021
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugsHugo Rolando Vaca, Ana María Celentano, María Agustina Toscanini, et al.International Journal for Parasitology|February 12, 2022
Identification and characterization of sirtuin enzymes in cestodes and evaluation of sirtuin inhibitors as new cestocidal moleculesHugo Rolando Vaca, Ana María Celentano, María Agustina Toscanini, et al.Journal of Medicinal Chemistry|March 4, 2016
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of SchistosomiasisTino Heimburg, Alokta Chakrabarti, Julien Lancelot, et al.European Journal of Medicinal Chemistry|December 17, 2017
Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiationJohannes Schulz-Fincke, Mirjam Hau, Jessica Barth, et al.Pageof 24